What is Nutranomics, Inc. (NNRX) stock price today?

Nutranomics, Inc. (NNRX) is currently trading at $0.00.

What is NNRX P/E ratio?

Nutranomics, Inc.'s P/E ratio is -0.07. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is NNRX return on equity (ROE)?

Nutranomics, Inc.'s return on equity (ROE) is 63.64%. ROE measures net income relative to shareholders' equity. Shareholders' equity is negative, so ROE is not a meaningful measure for this company.

What is Nutranomics, Inc.'s market cap?

Nutranomics, Inc. has a market capitalization of $816232.

OTC · Drug Manufacturers - Specialty & Generic

Nutranomics, Inc. (NNRX) Stock

$0.00 OTC: NNRX Healthcare

Nutranomics, Inc. focuses on the research, development, and marketing of health-focused nutritional products.

Valuation

Metric	Value
Price	$0.00
Market Cap	$816232
P/E Ratio	-0.07
P/B Ratio	-0.05
P/S Ratio	0.27
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	63.64%
ROA	-38.89%
ROCE	-315.83%
Gross Margin	-266.67%
Operating Margin	-266.67%
Net Margin	-233.33%
Debt/Equity	-1.36
Current Ratio	0.20

Annual Financials (USD)

Metric	2015	2019	2020	2021	2022
Revenue	$2.0M	$0	$0	$2.0M	$3.0M
Operating Profit	$-1.0M	$-1.0M	$-1.0M	$-2.0M	$-8.0M
Net Profit	$-1.0M	$-2.0M	$-1.0M	$-2.0M	$-7.0M
EPS	$-0.01	$0.00	$0.00	$0.00	$0.00
Op Margin	-46.7%	-963.3%	-68370.8%	-103.9%	-297.4%

Balance Sheet (USD)

Metric	2015	2019	2020	2021	2022
Total Assets	$0	$0	$0	$17.0M	$18.0M
Total Liabilities	$2.0M	$6.0M	$7.0M	$19.0M	$29.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$1.0M	$2.0M	$2.0M	$15.0M	$15.0M

Cash Flow (USD)

Metric	2015	2019	2020	2021	2022
Operating Cash Flow	$0	$0	$-1.0M	$-2.0M	$-6.0M
Investing Cash Flow	$0	$0	$0	$-1.0M	$3.0M
Financing Cash Flow	$0	$0	$1.0M	$2.0M	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$0	$0	$-1.0M	$-2.0M	$-6.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-3.81
FCF Yield	-728.56%
Quick Ratio	0.10
Interest Coverage	-18.32
Return 1Y	-50.00%
Return 3Y	-50.00%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ACURAcura Pharmaceuticals, Inc.	$0.00	—	0.00	$6600	0.00%
AXRXAmexdrug Corporation	$0.00	—	0.50	$33882	0.00%
ENDVEndonovo Therapeutics, Inc.	$0.00	—	1.00	$31875	0.00%
FLHLFFilament Health Corp.	$0.00	—	-1.89	$26179	0.00%
MEDDMedical Imaging Corp.	$0.00	—	0.00	$63819	0.00%

About Nutranomics, Inc.

Nutranomics, Inc. focuses on the research, development, and marketing of health-focused nutritional products. Their extensive catalog features nearly 500 distinct dietary supplements, encompassing formulations of vitamins, minerals, herbal remedies, and probiotics. Beyond its product offerings, the company provides innovative services, such as its Nutritional Blood Analysis—a diagnostic tool enabling customers to observe their blood cells live on a video monitor—and the patented Assimilation Enhancing System, which is engineered to optimize nutrient absorption. Additionally, Nutranomics delivers comprehensive educational resources, including various forms of analysis, training programs, professional certifications, and group presentations, catering to both individuals and industry experts. The distribution of its products occurs globally through a network of sales representatives across North America and Asia, alongside availability in retail stores. Nutranomics, Inc. also maintains a strategic alliance with Terra-Formance, LLC. Established in 1995, the company is based in Salt Lake City, Utah.

Nutranomics, Inc. (NNRX) stock trades at $0.00 with a market capitalization of $816232. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.07, reflecting a net loss over the last twelve months, a negative price-to-book of -0.05, reflecting negative shareholders' equity, price-to-sales of 0.27.

On profitability, Nutranomics, Inc. generates a return on equity (ROE) of 63.64% (not meaningful, as shareholders' equity is negative), return on capital employed of -315.83%, an operating margin of -266.67%, a net profit margin of -233.33%.

Official website: www.nutranomics.com